CNS Clinical Trials Are Prone To Duplicate Subjects and Duplicate Enrollment
CNS clinical trials, especially psychiatry clinical trials are prone to having duplicate subjects in clinical trials. In studies that rely upon subjective end points, there exists the ability to provide false information in an effort to gain entry in to the study. Of course, these occurrences result in failed trials due to elevated placebo rates
Duplicate Subjects In Clinical Trials Prevented By Verified Clinical Trials
Duplicate subjects in clinical trials has attracted the attention of many clinical trial managers and study leads. To prevent duplicate subjects or professional research subjects, many sponsors have added the use of Verified Clinical Trials (VCT) as a mandatory step during the screening process. VCT verifies a research subject’s study history at the time of
Duplicate Subjects In Clinical Trials Can Be Prevented With A Global Research Subject Registry
Duplicate subjects in clinical trials is unfortunately a common issue that affects all trials from most every indication and across all phases of clinical trials research. These professional research subjects can be prevented by using Verified Clinical Trials (VCT) the global research subject registry. Nearly all of the phase 1 units across the United States
Duplicate Subjects In Your Clinical Trials Result In Safety & Data Quality Issues
To maintain data integrity and safety, it is necessary to highlight and detect duplicate subjects in your clinical trials proactively. This is true for nearly all therapeutic indications and all phases of clinical trials research. Duplicate enrollment (over enrollment) is NOT just a healthy volunteer phase 1 issue. The global research subject database registry VCT data over the
Having a system, or research subject database registry, to proactively detect and prevent duplicate subjects and other protocol violations has become a well recognized and important step to protect the data quality and improve research subject safety. This is NOT limited to phase 1 healthy volunteer studies. This happens with significant frequency across multiple therapeutic
Bad Behavior in Clinical Trials: Strategies to Combat Duplicate Subjects & Research Participant Dishonesty/Deception, Non-adherence, and “Professional Subjects
Join us at #ASCP2019 in Phoenix this year Wed. May 29th at 1 PM as VCT hosts an expert panel on professional research subjects and duplicate subjects in CNS clinical trials. Duplicate subjects can ruin a trial, especially in the CNS space. Without a research subject database registry like Verified Clinical Trials it is nearly impossible
